MedTrace Logo

Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation

NCT01070615 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 693

Last updated 2010-03-02

No results posted yet for this study

Summary

Objectives: Evaluation of the clinical long-term safety, tolerability, patient satisfaction, pharmacokinetics and pattern of use of oral prucalopride tablets given in doses up to 4 mg once daily to patients with chronic constipation

Conditions

  • Chronic Constipation

Interventions

DRUG

Prucalopride

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • Marc Van Outryve, MD · University Hospital Antwerp, Edegem, Belgium

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-06-30
Primary Completion
2000-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01070615 on ClinicalTrials.gov